Efizonerimod alfa Uses, Dosage, Side Effects and more
Efizonerimod alfa is under investigation in clinical trial NCT02221960 (A Phase 1 Study to Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | Efizonerimod alfa |
| Generic | Efizonerimod alfa |
| Efizonerimod alfa Other Names | Efizonerimod alfa |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
